PND27 ESTIMATING MARGINAL COST-EFFECTIVENESS USING A PERSON-LEVEL NET BENEFITS APPROACH WITH AN APPLICATION TO DISEASE-MODIFYING DRUGS IN MULTIPLE SCLEROSIS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65365-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65365-X/fulltext
Title :
PND27 ESTIMATING MARGINAL COST-EFFECTIVENESS USING A PERSON-LEVEL NET BENEFITS APPROACH WITH AN APPLICATION TO DISEASE-MODIFYING DRUGS IN MULTIPLE SCLEROSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65365-X&doi=10.1016/S1098-3015(10)65365-X
First page :
Section Title :
Open access? :
No
Section Order :
523